Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
Status:
Unknown status
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to ascertain whether the withdrawal of calcineurin inhibitors
(CNI) will lead to less kidney transplant damage when compared with minimisation. The
investigators will assess this by comparing the degree of damage on kidney biopsies taken
before and after minimisation/withdrawal of CNI.